ATTITUDE TOWARDS INFLUENZA VACCINE AMONG THE GENERAL POPULATION OF LATVIA DURING THE COVID-19 PANDEMIC
DOI:
https://doi.org/10.17770/sie2021vol4.6263Keywords:
Vaccination, Covid-19 vaccine, adult population attitude to vaccinationAbstract
Annual influenza epidemics are associated with substantial morbidity and mortality, especially in elderly and in those with underlying diseases. During the global COVID-19 pandemic WHO and CDC have emphasized the importance of reducing risk of influenza virus spread and protecting high risk patient groups from complications caused by the influenza virus. Influenza vaccine may also reduce the burden on healthcare systems while we wait for a COVID-19 vaccine. Although the influenza vaccine has been around for a while, there are still many who question the efficiency, safety and usefulness of it. The article aims to study the attitude of the Latvian adult population towards influenza vaccine during the COVID-19 pandemic. Materials and methods: a quantitative, cross-sectional study based on an anonymous online survey consisting of 12 questions. Data was analysed by using descriptive statistics and Pearson correlation. Results: major part of the respondents do not support influenza vaccine, but almost a half support the vaccination or have changed their attitude towards it during the COVID-19 pandemic. Data shows lack of knowledge about influenza infection, influenza vaccine and vaccine side effects, therefore further educational campaigns should be developed for the general population.
References
Barker, W. H. (1986). Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health, 76(7), 761-765. DOI:10.2105/ajph.76.7.761
Centers for Disease Control and Prevention. (2020). CDC seasonal flu vaccine effectiveness studies. Retrieved from https://www.cdc.gov/flu/vaccines-work/effectiveness-studies.htm
Centers for Disease Control and Prevention. (2020). Seasonal Influenza Vaccine Safety: A Summary for Clinicians. Retrieved from https://www.cdc.gov/flu/professionals/vaccination/vaccine_safety.htm
David, A., Berlin, M. D., Roy, M., Gulick, M. D., Martinez, M. D. (2020). Severe COVID-19. N Engl J Med, 383, 2451-2460. DOI: 10.1056/NEJMcp2009575
Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., & Gulyaeva, A. A. (2020). Severe Acute Respiratory Syndrome-related Coronavirus: The Species and Its Viruses–A Statement of the Coronavirus Study Group. BioRxiv, 7. DOI: https://doi.org/10.1101/2020.02.07.937862
Yamauchi, Y. (2020). Influenza A virus uncoating. Adv Virus Res, 106, 1-38. DOI: 10.1016/bs.aivir.2020.01.001.
Kassianos, G., Blank, P., Falup-Pecurariu, O., Kuchar, E., Kyncl, J., Ortiz De Lejarazu, R., et al. (2016). Influenza vaccination: key facts for general practitioners in Europe—a synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands. Drugs in Context, 5, 212293. DOI: 10.7573/dic.212293
Pormohammad, A., Ghorbani, S., Khatami, A., Razizadeh, M.H., Alborzi, E., Zarei, M., et al. (2021). Comparison of influenza type A and B with COVID‐19: A global systematic review and meta‐analysis on clinical, laboratory and radiographic findings. Rev Med Virol e2179. DOI: https://doi.org/10.1002/rmv.2179
Ramos, M. I., Cubillas, J. J., Jurado, J. M. (2019). Prediction of the increase in health services demand based on the analysis of reasons of calls received by a customer relationship management. Int J Health Plann Manage, 34(2), 1215–1222. DOI: 10.1002/hpm.2763.
Rechel, B., Richardson, E., McKee, M. (2018). The Organization and Delivery of Vaccination Services in the European Union. European Observatory on Health Systems and Policies and European Commission. World Health Organisation, Geneva. Retrieved from http://www.euro.who.int/__data/assets/pdf_file/0008/386684/vaccination-report-eng.pdf?ua=1.
Schuster, M., Eskola, J., Duclos, P. (2015). Review of vaccine hesitancy: rationale, remit and methods, Vaccine, 33(34), 4157-4160.
Slimības profilakses un kontroles centrs. (2020). Pārskats par iedzīvotāju imunizāciju un imunizācijas valsts programmas ietvaros vakcinētajām personām 2018.gadā. Retrieved from https://www.spkc.gov.lv/sites/spkc/files/data_content/prskatu_par_iedzvotju_imunizciju_un_imunizcijas_valsts_programmas_ietvaros_vakcintajm_personm_2018.gad1.pdf
Slimības profilakses un kontroles centrs. (2020). Pārskats par iedzīvotāju imunizāciju un imunizācijas valsts programmas ietvaros vakcinētajām personām 2019.gadā. Retrieved from https://www.spkc.gov.lv/sites/spkc/files/content/latvija_2019.pdf
Slimības profilakses un kontroles centrs. (2020). Pārskats par iedzīvotāju imunizāciju un imunizācijas valsts programmas ietvaros vakcinētajām personām 2017.gadā. Retrieved from https://www.spkc.gov.lv/sites/spkc/files/data_content/vdl_5_6_latvija_2017_im1.pdf
Slimību profilakses un kontroles centrs. (2019). Pārskats par gripas un citu AAEI izplatību 2018.-2019. gada epidēmiskajā sezonā. Retrieved from https://www.spkc.gov.lv/sites/spkc/files/content/gripa_2018_2019_sezona_30_08_2019.pdf
The Medical Letter. (2020). Influenza Vaccine for 2020-2021. Retrieved from https://secure.medicalletter.org/w1607a
Zavadska, D., Isarova, D., Vīksna, L., Rezeberga, D., Gardovska, D. (2015). Literatūrā un uz pierādījumiem balstītas rekomendācijas gripas profilaksei. Retrieved from https://www.bkus.lv/sites/default/files/editor/gripas_rekomendacijas_2015.pdf
Downloads
Published
Issue
Section
How to Cite
